LivaNova completes feasibility study of Caisson TMVR system
UK-based medical technology company LivaNova has completed the PRELUDE feasibility study of its transcatheter mitral valve replacement (TMVR) system called…
mitral regurgitation
Abbott initiates clinical study of Tendyne device in US
Abbott has launched a clinical trial of its investigational Tendyne Transcatheter Mitral Valve Replacement (TMVR) device in the US to…